COSMOS Pharmaceutical
3349.T
Revenue for COSMOS Pharmaceutical (3349.T)
Revenue in 2023 (TTM): $5.97 B
According to COSMOS Pharmaceutical's latest financial reports the company's current revenue (TTM) is $5.97 B. In 2022 the company made a revenue of $6.07 B a decrease over the years 2021 revenue that were of $6.66 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for COSMOS Pharmaceutical from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $5.97 B | -1.56% |
| 2022 | $6.07 B | -8.89% |
| 2021 | $6.66 B | -2.07% |
| 2020 | $6.80 B | 16.21% |
| 2019 | $5.85 B | 10.19% |
| 2018 | $5.31 B | 12.57% |
| 2017 | $4.72 B | 8.38% |
| 2016 | $4.35 B | 25.48% |
| 2015 | $3.47 B | -5.95% |
| 2014 | $3.69 B | 3.96% |
| 2013 | $3.55 B | -6.93% |
| 2012 | $3.81 B | 18.32% |
| 2011 | $3.22 B | 28.16% |
| 2010 | $2.51 B | 19.9% |
| 2009 | $2.09 B |